N- (2-Methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermediate High Tsabta

Takaitaccen Bayani:

N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl) pyrimidin-2-amine

Saukewa: 152460-09

Bayyanar: Yellow ko Kusan Yellow Foda

Tsafta: ≥98.0% (HPLC)

Matsakaicin Imatinib Mesylate (CAS: 220127-57-1) a cikin jiyya na Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

Kyakkyawan inganci, Samar da Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl) pyrimidin-2-amine
Makamantu Imatinib Mesylate Intermediate;2- (2-Methyl-5-nitroanilino) -4- (3-pyridyl) pyrimidine
Lambar CAS 152460-09-8
Lambar CAT Saukewa: RF-PI228
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C16H13N5O2
Nauyin Kwayoyin Halitta 307.31
Matsayin narkewa 188.0 ~ 193.0 ℃
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Rawaya Ko Kusan Ruwan Foda
Tsafta ≥98.0% (HPLC)
Danshi (KF) ≤0.50%
Jimlar ƙazanta ≤2.0%
Matsakaicin Tsabtace Guda Daya ≤1.0%
Ragowa akan kunnawa ≤0.50%
Karfe masu nauyi ≤20ppm
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Imatinib Mesylate (CAS: 220127-57-1)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.

Amfani:

1

FAQ:

Aikace-aikace:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai samar da N- (2-Methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine (CAS: 152460-09-8) tare da high quality.Matsakaici ne yawanci a cikin haɗin Imatinib Mesylate (CAS: 220127-57-1).
Imatinib Mesylate karamin kwayoyin halitta ne wanda ke hana c-Abl protein-tyrosine kinase, Musamman musamman ga BCR-ABL, enzyme da ke hade da cutar sankarar jini na myelogenous (CML) da wasu nau'i na cutar sankarar lymphoblastic mai tsanani (ALL).Wani lamari mai canzawa tsakanin chromosomes 9 da 22 yana haifar da chromosome na Philadelphia, wanda sannan ya samar da furotin Bcr-Abl fusion tare da aikin kinase mai banƙyama wanda ke inganta yaduwar kwayar halitta.Imatinib Mesylate yana ɗaure wannan mahimmancin kinase, yana dakatar da haɓakar CML.An ƙara nuna Imatinib Mesylate don hana PDGFR da tyrosine kinases masu alaƙa da c-Kit.An yi amfani da nau'ikan da ke ɗauke da Imatinib Mesylate don magance cututtukan daji daban-daban.

Ku rubuta sakonku anan ku aiko mana